AbbVie (ABBV) Leases (2019 - 2025)

AbbVie (ABBV) has 7 years of Leases data on file, last reported at $44.0 million in Q4 2025.

• Leases for Q4 2025 came in at $44.0 million, down 93.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $44.0 million (down 93.91% YoY), and the FY2025 annual result was $44.0 million, down 93.91% from the prior year.
• Leases slipped to $44.0 million in Q4 2025 per ABBV's latest filing, from $723.0 million in the prior quarter.
• Over five years, Leases peaked at $723.0 million in Q4 2024 and troughed at $25.0 million in Q4 2022.
• A 5-year average of $172.0 million and a median of $35.0 million in 2023 frame the typical range for Leases.
• The sharpest annual moves came in 2024 and 2025: Leases jumped 1965.71% in 2024, then slumped 93.91% in 2025.
• A 5-year view of Leases shows it stood at $33.0 million in 2021, then retreated by 24.24% to $25.0 million in 2022, then soared by 40.0% to $35.0 million in 2023, then jumped by 1965.71% to $723.0 million in 2024, then tumbled by 93.91% to $44.0 million in 2025.
• Business Quant data shows ABBV's Leases at $44.0 million in Q4 2025, $723.0 million in Q4 2024, and $35.0 million in Q4 2023.